Association of plasma Fetuin-A and clinical characteristics in patients with new-onset type 2 diabetes mellitus

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 1, 2015, Pages 991-999

  Yin, Liang ^a   Cai, Wei Juan ^a   Zhu, Ling Yun ^a   Li, Jun ^a   Su, Xiang Hui ^a   Wang, Xiao Li ^a   Chang, Xiang Yun ^a   Sun, Kan ^a  

^a SHIHEZI UNIVERSITY   (China)

Author keywords

Carotid intima media thickness; Fetuin A; New onset type 2 diabetes mellitus

Indexed keywords

FETUIN A; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD SAMPLING; BODY MASS; CAROTID ARTERY DISEASE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DOPPLER FLOWMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

EID: 84923059795     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis:anepidemiologic view. Diabetes Metab Rev 1987; 3: 463-524.
2. Sibal L, Agarwal SC, Home PD. Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes. Diabetes Metab Syndr Obes 2011; 4: 23-34.
3. Sun Q, Cornelis MC, Manson JE, Hu FB. Plasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the U.S. Diabetes 2013; 62: 49-55.
4. Ix JH, Wassel CL, Kanaya AM, Vittinghoff E, Johnson KC, Koster A, Cauley JA, Harris TB, Cummings SR, Shlipak MG; Health ABC Study. Fetuin-A and incident diabetes mellitus in older persons. JAMA 2008; 300: 182-188.
5. Ix JH, Biggs ML, Mukamal KJ, Kizer JR, Zieman SJ, Siscovick DS, Mozzaffarian D, Jensen MK, Nelson L, Ruderman N, Djousse L. Association of fetuin-a with incident diabetes mellitus in community-living older adults: thecardiovascular health study. Circulation 2012; 125: 2316-2322.
6. Stefan N, Fritsche A, Weikert C, Boeing H, Joost HG, Häring HU, Schulze MB. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 2008; 57: 2762-2767.
7. Laughlin GA, Barrett-Connor E, Cummins KM, Daniels LB, Wassel CL, Ix JH. Sex-specific association of fetuin-A with type 2 diabetes in older community-dwelling adults: the Rancho Bernardo Study. Diabetes Care 2013; 36: 1994-2000.
8. Rasul S, Wagner L, Kautzky-Willer A. Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus. Endocrine 2012; 42: 496-505.
9. Song AY, Xu M, Bi YF, Xu Y, Huang Y, Li M, Wang T, Wu Y, Liu Y, Li X, Chen Y, Wang W, Ning G. Serum Fetuin-A Associates with Type 2 Diabetes and Insulin Resistance in Chinese Adults. PLoS One 2011; 6: e19228.
10. Mathews ST, Chellam N, Srinivas PR, Cintron VJ, Leon MA, Goustin AS, Grunberger G. Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol 2000; 164: 87-98.
11. Mathews ST, Singh GP, Ranalletta M, Cintron VJ, Qiang X, Goustin AS, Jen KL, Charron MJ, Jahnen-Dechent W, Grunberger G. Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes 2002; 51: 2450-2458.
12. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent W. The serum protein alpha 2-Heremans-Schmid glyco-protein/fetuin-A is a systematically acting inhibitor of ectopic calcification. J Clin Invest 2003; 112: 357-366.
13. Lorant DP, Hoellerl F, Grujicic M, Brix JM, Hoellerl F, Schernthaner G, Koppensteiner R, Schernthaner GH. Fetuin-A levels are increased in patients with type 2 diabetes and peripheral arterial disease. Diabetes Care 2011; 34: 156-161.
14. Eraso LH, Ginwala N, Qasim AN, Mehta NN, Dlugash R, Kapoor S, Schwartz S, Schutta M, Iqbal N, Mohler ER 3rd, Reilly MP. Association of lower plasma fetuin-A levels with peripheral arterial disease in type 2 diabetes. Diabetes Care 2010; 33: 408-410.
15. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
16. Alberti KG, Zimmet PZ. Definition, diagnosis and classification ofdiabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabetic Med 1998; 15: 539-553.
17. Freeman DJ, Norrie J, Sattar N. Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention study. Circulation 2001; 103: 357-362.
18. HhMatthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma gluco-se and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
19. Aydin M, Bulur S, Alemdar R, Yalçin S, Türker Y, Basar C, Aslantas Y, Yazgan Ö, Albayrak S, Özhan H; Melen Investigators. The impact of metabolic syndrome on carotid intima media thickness. Eur Rev Med Pharmacol Sci 2013; 17: 2295-2301.
20. Denecke B, Graber S, Schafer C, Heiss A, Woltje M, Jahnen-Dechent W. Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. Biochem J 2003; 376: 135-145.
21. Zhang Y, Zanotti I, Reilly MP, Glick JM, Rothblat GH, Rader DJ. Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo. Circulation 2003; 108: 661-663.
22. Chen HY, Chiu YL, Hsu SP, Pai MF, Lai CF, Peng YS, Kao TW, Hung KY, Tsai TJ, Wu KD. Association of serum fetuin A with truncal obesity and dyslipidemia in non-diabetic hemodialysis patients. Eur J Endocrinol 2009; 160: 777-783.
23. Roos M, Oikonomou D, von Eynatten M, Luppa PB, Heemann U, Lutz J, Baumann M, Nawroth PP, Bierhaus A, Humpert PM. Associations of fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy. Cardiovasc Diabetol 2010; 9: 48.
24. Ramadan A, Shoukry A, Ismail MI, Borai M. Serum fetuin-A levels in type 2 diabetes patients with early diabetic nephropathy: it’s relation to diabetes control. J Am Sci 2011; 7: 759-765.
25. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Kröber SM, Machicao F, Fritsche A, Häring HU. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006; 29: 853-857.
26. Mori K, Emoto M, Yokoyama H, Araki T, Teramura M, Koyama H, Shoji T, Inaba M, Nishizawa Y. Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. Diabetes Care 2006; 29: 468.